drugset / Trial / NCT00532350

Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

NCT00532350

Phase 1 Completed 22 enrolled Novartis
RandomizedCrossoverDouble-blindTreatment

Summary

This study will assess the safety and tolerability of QAT370 compared to tiotropium in patients with COPD.

Timeline

Start
2007-07
Primary completion
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject QAT370 Unknown
Comparator Tiotropium Other / unclassified